European pharmaceutical companies, european pharmaceutical companies.#European #pharmaceutical #companies


Posted On Jul 7 2018 by

european pharmaceutical companies

European pharmaceutical companies

  • Member Center
    • Resources
      • Event List
      • Event Calendar
      • ISMPP Job Board
        • November Job Board
      • ISMPP Ambassador Tools
      • Code of Ethics
      • the map, ISMPP’s Newsletter
        • the map 2017
      • Sunshine Act Resources
    • Initiatives
      • Advocacy
      • GAPP
      • GPP3
        • GPP3 Endorsements
        • GPP3 FAQs
        • GPP3 Translations
      • MPIP
    • Certification
      • Overview
      • Code of Conduct
      • Benefits
      • Exam Details
      • CMPP Study Resources
        • CMPP Critical References
        • CMPP Supplemental References
        • CMPP Useful Websites
      • Recertification
      • CMPP Governance
      • CMPP Directory
      • Mentor Program
    • Education
      • Annual Meeting
        • Exhibits Sponsorships
        • AM Call for Abstracts
        • Attendee List
        • AM Faculty Bios
      • European Meeting
        • Register Now!
        • European Meeting Faculty
        • 2018 Exhibit Sponsor Opportunities
          • Exhibitor Kit
        • 2017 Presentations/Posters
      • Asia Pacific Meetings
        • Exhibits Sponsorships AP
        • AP Schedule of Events
        • 2017 AP Faculty
      • ISMPP U
        • ISMPP U Sponsorship
      • Other Educational Events
      • ISMPP Meeting Highlights
      • ISMPP Media Partners
    • Committees
      • Overview
      • Asia-Pacific Platform
      • European Platform
      • Education Platform
      • Membership Platform
      • Outreach Platform
      • Standards Guidelines Platform
      • Credentialing Platform
    • About Us
      • Mission and Vision
      • Join
      • Member Benefits
      • Governance
      • ISMPP Sponsors
        • Corporate Sponsorship Program
      • Contact Us

    GPP2 Guidelines, 2009

    To address legislative, guidance, and ethical developments since 2003, and to reinforce the aims of the original 2003 publication, the International Society for Medical Publication Professionals (ISMPP) convened a Steering Committee to develop a revised Good Publication Practice document which is now known as GPP2 .

    The Committee s work, GPP2, was independently peer reviewed and published:

    Graf C, Battisti WP, Bridges D, et al. for the International Society of Medical Publication Professionals. Good publication practice for communicating company sponsored medical research: the GPP2 guidelines. BMJ 2009;339:b4330.

    GPP2 provides comprehensive guidance on a number of key issues, including:

    Roles of authors, sponsors, and other contributors

    Reimbursement and honoraria

    How to establish a publication steering committee

    Role of professional medical writers

    Recommendations for publication planning and documentation

    Supporting Materials

    GPP2 presentation by Chris Graf

    The Medical Roundtable

    ISMPP thanks The Medical Roundtable for allowing ISMPP members to download “GPP2: Good Publication Practices for Sponsored Medical Research: Elevating the Integrity of Scientific Communications.” Click here to read the article.

    Frequently Asked Questions

    GPP Historical Archive

    GPP Guidelines, 2003

    The landmark guidelines on Good Publication Practice (GPP) published in 2003 were developed with the aim of ensuring that clinical trials sponsored by pharmaceutical companies are published in a responsible and ethical manner.”

    Wager E, Field EA, Grossman L. Good publication practice for pharmaceutical companies. Curr Med Res Opin 2003;19:149-154.

    Click here to read the Editorial that accompanied the original GPP


    Last Updated on: July 7th, 2018 at 3:22 pm, by


    Written by admin


    Leave a Reply

    Your email address will not be published. Required fields are marked *